What is Superior Oblique Myokymia?

Superior Oblique Myokymia (SOM) is a rare neurological and ophthalmological condition characterized by brief, involuntary, high-frequency contractions of the superior oblique muscle of the eye. These microscopic twitches cause the affected eye to move rapidly in a rotating and vertical direction, which can lead to visual disturbances.

SOM is considered a form of "microtremor" of the trochlear nerve, which innervates the superior oblique muscle. The condition is typically benign, meaning it does not lead to permanent vision loss or progressive eye muscle damage, but it can be highly bothersome for those who experience it.

Symptoms of SOM

The hallmark symptom of Superior Oblique Myokymia is monocular oscillopsia, a sensation that objects in the visual field are jiggling, shimmering, or moving out of alignment in one eye only. Patients often describe the visual disturbance as a brief "wobble" or "flutter" that lasts for a second or two.

Common symptoms include:

• Intermittent vertical or torsional (rotational) double vision, known as diplopia.
• A subjective feeling of the eye "pulling" or "quivering" without visible outward movement in most cases.
• Difficulty maintaining steady gaze, especially when reading or looking downwards.
• Episodes can be triggered by fatigue, stress, anxiety, or certain eye movements, such as looking down and to the side.
• Episodes may occur in clusters of multiple twitches per minute, followed by periods of remission that last for days, weeks, or even months.

What Causes SOM?

The exact cause of Superior Oblique Myokymia is not fully understood. The condition is believed to arise from abnormal, spontaneous electrical discharges in the trochlear nerve (the fourth cranial nerve), which supplies the superior oblique muscle. These discharges cause the muscle to contract involuntarily.

Potential contributing factors identified in some cases include:

• Microvascular compression: A blood vessel pressing against the trochlear nerve at the brainstem, a mechanism similar to that seen in trigeminal neuralgia.
• Prior head trauma or concussion, which may irritate the nerve.
• Trochlear nerve palsy that has partially resolved, leaving the nerve hyperexcitable.
• Rarely, a tumour or demyelinating lesion along the nerve pathway, though this is uncommon.

In many instances, no underlying structural cause is found, and the condition is labelled idiopathic.

Diagnosis

Diagnosis of Superior Oblique Myokymia is primarily clinical, based on the patient's description of symptoms. The intermittent nature of the twitching means it is often difficult to observe the eye movements during a standard examination.

An ophthalmologist or neurologist may use the following methods:

• Slit-lamp examination: High magnification of the eye may occasionally capture the fine torsional movements of the globe.
• Fundoscopy: The doctor may observe movement of the optic nerve head, which mirrors rotation of the eye.
• Eye movement recordings: Specialized equipment can detect the high-frequency, low-amplitude oscillations characteristic of SOM.
• Magnetic resonance imaging (MRI): Imaging is typically performed to rule out structural causes such as a vascular compression, tumour, or demyelinating lesion along the trochlear nerve.

Treatment Options

Treatment is not always required, especially if symptoms are mild and infrequent. Many patients are reassured simply by learning that the condition is benign and not a sign of a serious disease.

When treatment is necessary, options include:

• Medications: Anticonvulsant and membrane-stabilizing drugs such as carbamazepine, gabapentin, or phenytoin have been shown to reduce or eliminate symptoms in some patients, though they may not work for everyone. Beta-blockers such as propranolol have also been tried.
• Surgery: In refractory, severe cases, surgical intervention on the superior oblique muscle or tendon may be considered. Procedures include tenotomy, myectomy, or weakening of the muscle with a suture. Surgery is generally reserved for patients who cannot tolerate or do not respond to medication.

Because SOM tends to have a fluctuating course, with spontaneous remissions, treatment decisions are individualized and often delayed until the frequency and severity of episodes justify intervention.